Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong · Delayed Price · Currency is HKD 3.460
0.00 (0.00%)
At close: Feb 13, 2026
Zhaoke Ophthalmology Market Cap
Zhaoke Ophthalmology has a market cap or net worth of 1.9 billion as of February 13, 2026. Its market cap has increased by 149.76% in one year.
Market Cap
1.90B
Enterprise Value
1.04B
Revenue
38.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.46
Market Cap Chart
Since April 29, 2021, Zhaoke Ophthalmology's market cap has decreased from 7.66B to 1.90B, a decrease of -75.26%. That is a compound annual growth rate of -25.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.90B | 16.89% |
| Dec 31, 2025 | 1.62B | 147.49% |
| Dec 31, 2024 | 655.37M | -69.49% |
| Dec 29, 2023 | 2.15B | 30.79% |
| Dec 30, 2022 | 1.64B | -46.83% |
| Dec 31, 2021 | 3.09B | -59.69% |
| Apr 29, 2021 | 7.66B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SinoMab BioScience | 2.41B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 2.40B |
| Antengene Corporation | 2.37B |
| Mabpharm | 2.10B |
| Frontage Holdings | 2.09B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.93B |
| Cutia Therapeutics | 1.84B |
| Immunotech Biopharm | 1.54B |